258 related articles for article (PubMed ID: 31558567)
1. Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis.
Xiao Y; Hill MC; Li L; Deshmukh V; Martin TJ; Wang J; Martin JF
Genes Dev; 2019 Nov; 33(21-22):1491-1505. PubMed ID: 31558567
[TBL] [Abstract][Full Text] [Related]
2. Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis.
Zheng M; Li RG; Song J; Zhao X; Tang L; Erhardt S; Chen W; Nguyen BH; Li X; Li M; Wang J; Evans SM; Christoffels VM; Li N; Wang J
Circulation; 2022 Nov; 146(22):1694-1711. PubMed ID: 36317529
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of Lats1 and Lats2 highlights the role of hippo pathway effector YAP in larynx and vocal fold epithelium morphogenesis.
Mohad V; Lungova V; Verheyden J; Thibeault SL
Dev Biol; 2021 May; 473():33-49. PubMed ID: 33515576
[TBL] [Abstract][Full Text] [Related]
4. Hippo Signaling Plays an Essential Role in Cell State Transitions during Cardiac Fibroblast Development.
Xiao Y; Hill MC; Zhang M; Martin TJ; Morikawa Y; Wang S; Moise AR; Wythe JD; Martin JF
Dev Cell; 2018 Apr; 45(2):153-169.e6. PubMed ID: 29689192
[TBL] [Abstract][Full Text] [Related]
5. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑93 promotes angiogenesis and attenuates remodeling via inactivation of the Hippo/Yap pathway by targeting Lats2 after myocardial infarctionω.
Ma C; Peng P; Zhou Y; Liu T; Wang L; Lu C
Mol Med Rep; 2020 Jul; 22(1):483-493. PubMed ID: 32319642
[TBL] [Abstract][Full Text] [Related]
7. Neddylation mediates ventricular chamber maturation through repression of Hippo signaling.
Zou J; Ma W; Li J; Littlejohn R; Zhou H; Kim IM; Fulton DJR; Chen W; Weintraub NL; Zhou J; Su H
Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E4101-E4110. PubMed ID: 29632206
[TBL] [Abstract][Full Text] [Related]
8. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
[TBL] [Abstract][Full Text] [Related]
9. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
[TBL] [Abstract][Full Text] [Related]
10. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
[TBL] [Abstract][Full Text] [Related]
11. Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function.
Mia MM; Cibi DM; Ghani SABA; Singh A; Tee N; Sivakumar V; Bogireddi H; Cook SA; Mao J; Singh MK
Cardiovasc Res; 2022 Jun; 118(7):1785-1804. PubMed ID: 34132780
[TBL] [Abstract][Full Text] [Related]
12. The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland.
Szymaniak AD; Mi R; McCarthy SE; Gower AC; Reynolds TL; Mingueneau M; Kukuruzinska M; Varelas X
Elife; 2017 May; 6():. PubMed ID: 28492365
[TBL] [Abstract][Full Text] [Related]
13. Targeted Disruption of Lats1 and Lats2 in Mice Impairs Testis Development and Alters Somatic Cell Fate.
Abou Nader N; Ménard A; Levasseur A; St-Jean G; Boerboom D; Zamberlam G; Boyer A
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362374
[TBL] [Abstract][Full Text] [Related]
14.
Tsoi M; Morin M; Rico C; Johnson RL; Paquet M; Gévry N; Boerboom D
FASEB J; 2019 Oct; 33(10):10819-10832. PubMed ID: 31268774
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.
Huntoon CJ; Nye MD; Geng L; Peterson KL; Flatten KS; Haluska P; Kaufmann SH; Karnitz LM
Cancer Res; 2010 Nov; 70(21):8642-50. PubMed ID: 20841485
[TBL] [Abstract][Full Text] [Related]
16.
St-Jean G; Tsoi M; Abedini A; Levasseur A; Rico C; Morin M; Djordjevic B; Miinalainen I; Kaarteenaho R; Paquet M; Gévry N; Boyer A; Vanderhyden B; Boerboom D
Development; 2019 Oct; 146(20):. PubMed ID: 31575647
[TBL] [Abstract][Full Text] [Related]
17. Acetylcytidine modification of Amotl1 by N-acetyltransferase 10 contributes to cardiac fibrotic expansion in mice after myocardial infarction.
Wang XX; Zhao YM; Zhang QY; Zhao JX; Yin DH; Zhang ZZ; Jin XY; Li SN; Ji HY; Chen HY; Guo XF; Yu Y; Ma WY; Yan H; Li H; Ou-Yang QM; Pan ZW; Liang HH; Wang N; Chen W; Cai BZ; Liu Y
Acta Pharmacol Sin; 2024 Jul; 45(7):1425-1437. PubMed ID: 38839936
[TBL] [Abstract][Full Text] [Related]
18. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC
Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
20. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
